World's first jab to stop skin cancer being tested in UK patients
- A personalized mRNA cancer jab is being tested in British patients for melanoma, with potential to target bladder, lung, and kidney cancer.
- In a trial, the jab reduced the risk of cancer recurrence in melanoma patients, leading to a final trial launch.
- The therapy involves DNA sequencing of a tumor sample and artificial intelligence, showing promising results for high-risk melanoma patients.
Insights by Ground AI
Does this summary seem wrong?
20 Articles
20 Articles
All
Left
4
Center
5
Right
3
Coverage Details
Total News Sources20
Leaning Left4Leaning Right3Center5Last UpdatedBias Distribution42% Center
Bias Distribution
- 42% of the sources are Center
42% Center
L 33%
C 42%
R 25%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage